Study to determine if AZD0284 is effective and safe in treating plaque psoriasis

Trial Identifier:	D7800C00003
Sponsor:	AstraZeneca
NCTID::	NCT03310320
Start Date:	November 2017
Primary Completion Date:	April 2018
Study Completion Date:	April 2018
Condition:	Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Danish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Denmark	Aarhus C, Denmark, 8000
Denmark	Hellerup, Denmark, 2900
Denmark	Koebenhavn, Denmark, 2400
Denmark	Odense C, Denmark, 5000

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.